Durkin Bryan T 4

What Happened

• Bryan T. Durkin, a director of CME Group Inc. (CME), sold 4,200 shares of CME Group Class A common stock in an open-market transaction on February 23, 2026.
• The filing reports a weighted-average sale price of $309.65 per share (range: $309.25–$310.07), yielding proceeds of approximately $1,300,530. This transaction is a sale (disposition), which is generally a liquidity event rather than a direct bullish signal.

Key Details

• Transaction date: February 23, 2026. Reported weighted-average price: $309.65; price range: $309.25–$310.07.
• Shares sold: 4,200; proceeds ≈ $1,300,530.
• Shares owned after the transaction: Not specified in the provided filing.
• Footnote: The sale prices within a $1 range were aggregated for reporting; the company keeps a record and can provide copies on request.
• No 10b5-1 plan, tax-withholding, or other special code disclosed in the provided summary.
• Filing date matches the transaction date (Feb 23, 2026), indicating the report appears timely.

Context

• This was a straightforward sale by a director. Sales are common for liquidity or portfolio management and, by themselves, are less informative about future company performance than insider purchases. The filing aggregates multiple sale prices into a weighted average for reporting clarity.